Welcome to CDC Stacks | NIOSH list of antineoplastic and other hazardous drugs in healthcare settings 2010 - 5743 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
NIOSH list of antineoplastic and other hazardous drugs in healthcare settings 2010
Filetype[PDF - 7.88 MB]


This document cannot be previewed automatically as it exceeds 5 MB
Please click the thumbnail image to view the document.
NIOSH list of antineoplastic and other hazardous drugs in healthcare settings 2010
Details:
  • Corporate Authors:
    National Institute for Occupational Safety and Health
  • Series:
    DHHS publication ; no. (NIOSH) 2010-167
  • Document Type:
  • Description:
    In this Alert, NIOSH presents a standard precautions or universal precautions approach to handling hazardous drugs safely: that is, NIOSH recommends that all hazardous drugs be handled as outlined in this Alert. Therefore, no attempt has been made to perform drug risk assessments or propose exposure limits. The area of new drug development is rapidly evolving as unique approaches are being taken to treat cancer and other serious diseases.

    "The National Institute for Occupational Safety and Health (NIOSH) Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings was published in September 2004 (http://www.cdc.gov/niosh/docs/2004-165/). In Appendix A of the Alert, NIOSH identified a sample list of major hazardous drugs. The list was compiled from information provided by four institutions that have generated lists of hazardous drugs for their respective facilities and by the Pharmaceutical Research and Manufacturers of America (PhRMA) from the American Hospital Formulary Service Drug Information (AHFS DI) monographs [ASHP/AHFS DI 2003]. This update adds 21 drugs to the original list in the 2004 Alert. These additions are new drugs or existing drugs that had new warnings from 2004 to 2007. The review process for the addition of the new listings is described in the Federal Register: http://www.cdc.gov/niosh/docket/pdfs/NIOSH-105-A/0105-A-042909-FR_Notice.pdf." - NIOSHTIC-2

    CDC-INFO Pub ID 2004165

  • Supporting Files:
    No Additional Files